You are here

Double Blind Atorvastatin Amlodipine Study

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Rijeka, , Croatia
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Angina
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
21-80 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Holter monitoring at baseline which demonstrates a total of 15 minutes of ischemia
and/or 3 ischemic events per 48 hours.

- Total cholesterol > 5.2 mmol/L (200 mg/dL) on diet alone.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Myocardial infarction within 2 months prior to the study.

- Likelihood of requiring treatment during the study period with drugs not permitted by
the study protocol.

NCT00159718
Pfizer
Completed
Double Blind Atorvastatin Amlodipine Study

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now